Difference between revisions of "HAN5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(8 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
+ | |||
+ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big> | ||
Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS) | + | | |
+ | ==== CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 301: | Line 304: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (NASOPHARYNGEAL TUMOURS) | + | | |
+ | ==== CHAPTER 3 (NASOPHARYNGEAL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 365: | Line 369: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS) | + | | |
+ | ==== CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 495: | Line 500: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (SALIVARY GLAND TUMOURS) | + | | |
+ | ==== CHAPTER 5 (SALIVARY GLAND TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 944: | Line 950: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS) | + | | |
+ | ==== CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,140: | Line 1,147: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS)) | + | | |
+ | ==== CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS)) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,193: | Line 1,201: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS) | + | | |
+ | ==== CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,818: | Line 1,827: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 9 (EAR TUMOURS) | + | | |
+ | ==== CHAPTER 9 (EAR TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,992: | Line 2,002: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 10 (SOFT TISSUE TUMOURS) | + | | |
+ | ==== CHAPTER 10 (SOFT TISSUE TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,364: | Line 2,375: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) | + | | |
+ | ==== CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,626: | Line 2,638: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 12 (MELANOCYTIC TUMOURS) | + | | |
+ | ==== CHAPTER 12 (MELANOCYTIC TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,657: | Line 2,670: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES) | + | | |
+ | ==== CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,765: | Line 2,779: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 14 (GERM CELL TUMOURS) | + | | |
+ | ==== CHAPTER 14 (GERM CELL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,796: | Line 2,811: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 15 (METASTASIS) | + | | |
+ | ==== CHAPTER 15 (METASTASIS) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,827: | Line 2,843: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA) | + | | |
+ | ==== CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,913: | Line 2,930: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK) | + | | |
+ | ==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,946: | Line 2,964: | ||
|[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]] | |[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]] | ||
Line 2,979: | Line 2,997: | ||
|[[HAN5:Cowden_syndrome|Cowden syndrome]] | |[[HAN5:Cowden_syndrome|Cowden syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | |[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | ||
Line 3,001: | Line 3,019: | ||
|[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] | |[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]] | |[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]] | ||
Line 3,034: | Line 3,052: | ||
|[[HAN5:Fanconi_anaemia|Fanconi anaemia]] | |[[HAN5:Fanconi_anaemia|Fanconi anaemia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]] | |[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]] | ||
Line 3,056: | Line 3,074: | ||
|[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | |[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Bloom_syndrome|Bloom syndrome]] | |[[HAN5:Bloom_syndrome|Bloom syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | |[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] |
Latest revision as of 14:07, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.